Clinical Trial Update: Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic) [NA]

View source ↗

Summary

A completed study evaluating the efficacy and tolerability of topical Rossoseq compared with vehicle in rosacea subtype 1 (erythematotelangiectatic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Rossoseq

Snippet

Sponsor: PBB Entrepreneur Ltd. | Conditions: Rosacea Subtype 1 (Erythematotelangiectatic) | NA | Status: COMPLETED